Mutations, methylation and expression of CDKN2α/p16 gene in colorectal cancer and normal colonic mucosa

被引:22
|
作者
Trzeciak, L
Hennig, E
Kolodziejski, J
Nowacki, M
Ostrowski, J
机构
[1] Med Ctr Postgrad Educ, Inst Oncol, Ctr Canc, Dept Gastroenterol, PL-02781 Warsaw, Poland
[2] Maria Sklodowska Curie Mem Canc Ctr, Dept Colorectal Dis, PL-02781 Warsaw, Poland
关键词
colorectal neoplasms; DNA methylation; cell cycle proteins; CDKN2a/pl6; gene;
D O I
10.1016/S0304-3835(00)00652-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The status of CDKN2 alpha gene, coding for p16 and p19ARF proteins, was examined in 55 colorectal cancers. Polymerase chain reaction (PCR), single stranded conformational polymorphism and sequencing revealed 1 case of CDKN2 alpha mutation. Methylation-specific PCR detected p16 locus methylation in 37 (73%) of 51 normal samples and 29 (53%) of 55 cancers (P = 0.035). p16 transcript absence (assessed by reverse transcription-polymerase chain reaction) was noted in 10 (45%) of 22 normal samples and four (14%) of 29 cancers (P = 0.012) and correlated with gene methylation (P = 0.036). The decreasing frequency of p16 silencing in cancer comparing to normal mucosa does not support the postulated role of p16 in colorectal carcinogenesis. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 50 条
  • [1] Methylation status of p16 gene in colorectal carcinoma and normal colonic mucosa
    Zhang, J
    Lai, MD
    Chen, J
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 1999, 5 (05) : 451 - 454
  • [2] Methylation status of p16 gene in colorectal carcinoma and normal colonic mucosa
    ZHANG Jing
    LAI Mao-De and CHEN Jian(Department of Clinical Pathology
    [J]. World Journal of Gastroenterology, 1999, (05) : 451 - 454
  • [3] Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas
    Esteve, A
    MartelPlanche, G
    Sylla, BS
    Hollstein, M
    Hainaut, P
    Montesano, R
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1996, 66 (03) : 301 - 304
  • [4] CDKN2 (P16) MUTATIONS IN AUSTRALIAN MELANOMA KINDREDS
    WALKER, GJ
    FLORES, JF
    HUSSUSSIAN, CJ
    GLENDENING, JM
    DRACOPOLI, NC
    HAYWARD, NK
    FOUNTAIN, JW
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 426 - 426
  • [5] Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation
    Costello, JF
    Berger, MS
    Huang, HJS
    Cavenee, WK
    [J]. CANCER RESEARCH, 1996, 56 (10) : 2405 - 2410
  • [6] Analysis on point mutation of the cdkn2/p16 gene in lung cancer
    Su, Changqing
    Ye, Yukun
    Wang, Dong
    Cao, Xiangrong
    Li, Shufeng
    Shan, Xiangnian
    [J]. Chinese Journal of Medical Genetics, 2002, 19 (01) : 37 - 40
  • [7] Inactivation of the p16/CDKN2 gene in carcinomas of the hypopharynx
    Liengswangwong, U
    Konishi, N
    Hiasa, Y
    Naito, H
    Yane, K
    [J]. CANCER LETTERS, 1999, 143 : S33 - S33
  • [8] DNA hypomethylation and gene expression of p16/CDKN2 in breast carcinoma.
    Calvano, JE
    Bisogna, M
    VanZee, KJ
    [J]. FASEB JOURNAL, 1997, 11 (03): : 584 - 584
  • [9] MUTATIONS OF THE CDKN2/P16(INK4) GENE IN AUSTRALIAN MELANOMA KINDREDS
    WALKER, GJ
    HUSSUSSIAN, CJ
    FLORE, JF
    GLENDENING, JM
    HALUSKA, FG
    DRACOPOLI, NC
    HAYWARD, NK
    FOUNTAIN, JW
    [J]. HUMAN MOLECULAR GENETICS, 1995, 4 (10) : 1845 - 1852
  • [10] Focal distribution of p16/CDKN2 gene mutations within individual prostate carcinomas
    Konishi, N
    Hiasa, Y
    Tao, M
    Matsuda, H
    Nakamura, M
    Yane, K
    Kitahori, Y
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 8 (03) : 549 - 554